Medication info

HDB-San (Sodium Bicarbonate)

Prescription medication
Ingredient · strength
Sodium Bicarbonate›1g / 1g
Manufacturer / importer
Nukis Co., Ltd.
Appearance
White crystals or crystalline powder in a polypropylene container, odorless with a distinct salty taste.
Packaging
Container - 650 grams/container, Container - 720 grams/container
Approval status
Active

MFDS item code 202500548 · Approved 2025.03.11 · Insurance code 677402401,677402411

Summary

Main use
Hemodialysis treatment for renal failure and detoxification in cases of poisoning
Who uses it
Adults
Adult dosage
1. When the specified acetate-containing dialysate (Solution A) is used, this product can be used to prepare approximately 180 L of bicarbonate-based hemodialysis dialysate containing 38mEq/L of HCO3-. 2. Use as dialysate for hemodialysis with a bicarbonate-based dialysate delivery system at a dilution ratio of 1 part acetate-containing dialysate (Solution A) to 34 parts (this medicine + purified water). 3. The mixing ratio for preparing dialysate for one treatment per patient (based on 6 hours) is as follows: Solution A : (sodium bicarbonate + purified water) = 5L : (650g + 170L) 4. For routine bicarbonate-based hemodialysis, use a dialysate delivery system and adjust the electrolyte concentrations as follows: Na+ : 140mEq/L HCO3- : 34mEq/L

Ingredients

Manufacturer
Nukis Co., Ltd.

Efficacy & effects

Hemodialysis treatment for renal failure and detoxification in cases of poisoning

View approved original text

This medication is used to prepare the dialysis fluid necessary for patients with acute and chronic renal failure undergoing hemodialysis. It is also utilized in the dialysis treatment for patients with toxic substance poisoning. Primarily, it aids in the removal of waste products in patients with impaired kidney function and helps maintain electrolyte balance. This dialysis fluid enables safe and effective hemodialysis treatment, thus playing an important role in the treatment of renal failure and toxic substance poisoning patients.

Dosage and Administration

Adult dosage

1. When the specified acetate-containing dialysate (Solution A) is used, this product can be used to prepare approximately 180 L of bicarbonate-based hemodialysis dialysate containing 38mEq/L of HCO3-. 2. Use as dialysate for hemodialysis with a bicarbonate-based dialysate delivery system at a dilution ratio of 1 part acetate-containing dialysate (Solution A) to 34 parts (this medicine + purified water). 3. The mixing ratio for preparing dialysate for one treatment per patient (based on 6 hours) is as follows: Solution A : (sodium bicarbonate + purified water) = 5L : (650g + 170L) 4. For routine bicarbonate-based hemodialysis, use a dialysate delivery system and adjust the electrolyte concentrations as follows: Na+ : 140mEq/L HCO3- : 34mEq/L

Precautions

This medication should not be used in patients with low blood pressure or rapid heart rate. Patients with pulmonary edema, abnormal electrocardiograms, high blood potassium levels, and those with bleeding problems should also not be administered this medication. Caution is advised in patients with severe liver disease or diabetes that complicates acetic acid metabolism, as this may result in symptoms of low blood pressure. Furthermore, patients on digitalis medications may experience symptoms of toxicity due to decreased serum potassium levels. Patients showing elevated serum calcium and phosphorus levels prior to hemodialysis should be cautious as this drug may lead to ectopic calcification. Hypoglycemic symptoms may arise in patients with inadequate caloric intake or among diabetic patients with dietary restrictions or using blood glucose-lowering agents. This drug may induce hypoglycemia during or after dialysis; if hypoglycemic symptoms occur, appropriate measures such as glucose injections or sugar supplementation should be taken. Additionally, serum calcium levels may rise, and if hypercalcemia occurs, it may be necessary to switch to a dialysis fluid with lower calcium concentration. Osteoporotic, osteomalacic, and fibrous osteitis complications may occur, necessitating appropriate treatment such as the administration of active vitamin D3 preparations. Phosphate binders may also be used to maintain serum phosphate levels within normal ranges. Dialysis disequilibrium syndrome may occur, leading to symptoms such as headache, nausea, vomiting, seizures, and altered consciousness, in which case it is necessary to reduce the dialysis speed or take other measures. Cardiovascular side effects may present as low blood pressure or shock; these symptoms necessitate discontinuation of dialysis or reducing dialysis efficiency, along with administering fluids or pressor agents. In rare cases, blood pressure may rise, in which case it is preferable to administer antihypertensive agents or switch to acetate dialysis solutions. This medication is utilized in the hemodialysis of chronic renal failure patients and is used when metabolic acidosis is not improving or when dialysis disequilibrium syndrome or significant low blood pressure occurs. It is also used for patients with difficulty managing blood sugar levels due to high blood sugar, employing a dialysis solution that does not contain glucose. Regular blood tests to check electrolytes, acid-base balance, blood urea nitrogen, creatinine, uric acid, blood glucose, etc., are recommended to monitor the patient's condition. Pregnant women or those who may become pregnant should use this medication only when the benefits outweigh the risks, as its safety has not been established. Safety has not been confirmed for pediatric patients, hence caution is advised, and elderly patients should use this medication considering its characteristics, alongside regular checks and appropriate measures for potential bone complications with long-term use. Dialysis diluents must utilize purified water, and precautions should be taken for potential bleeding tendencies caused by anticoagulant administration or damage to dialysis membranes. During preparation, do not use the electrolyte solution for artificial kidney dialysis alone with this drug solution; it must be precisely prepared with the specified diluent. Be cautious of excessive or insufficient diluent concentration, as it may lead to symptoms such as headache, palpitations, blood pressure abnormalities, and altered consciousness. It is advisable to confirm the electrolyte concentration and pH of the dialysis fluid before use, and the prepared dialysis fluid should be used immediately. Furthermore, it should not be used for injections or peritoneal lavage. The balance between serum osmotic pressure in dialysis patients and the osmotic pressure in the dialysis fluid must be maintained, with an optimal usage temperature around body temperature. The cartridge used for this medication is only compatible with specific dialysis systems and should be protected from excessive pressure or negative pressure.

Side effects

  • Hypoglycemia
  • hypercalcemia
  • osteoporosis
  • osteomalacia
  • fibrous osteitis
  • ectopic calcification
  • headache
  • nausea
  • vomiting
  • convulsions
Show 13 more
  • altered consciousness
  • discomfort
  • lethargy
  • hypotension
  • shock symptoms
  • increased blood pressure
  • headache
  • palpitations
  • altered consciousness
  • limb paralysis sensation
  • generalized fatigue
  • chest discomfort
  • rapid blood pressure drop

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or humidity from entering, ideally at room temperature between 1 to 30 degrees Celsius. Proper storage ensures the maintenance of the drug's effectiveness and prevents degradation.

Appearance and packaging

Appearance

White crystals or crystalline powder in a polypropylene container, odorless with a distinct salty taste.

Package unit

Container - 650 grams/container, Container - 720 grams/container

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.